-

Lawsuit Alert: Investors who lost money with Adobe Inc. (NASDAQ: ADBE) shares should contact the Shareholders Foundation in connection with Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in Adobe Inc. (NASDAQ: ADBE) shares in the U.S. District Court for the Southern District of New York (No: 23-CV-09260).

A lawsuit is pending for certain investors in Adobe Inc. shares. Investors in NASDAQ: ADBE should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Share

Investors who purchased shares of Adobe Inc. prior to June 2021 and continue to hold any of those NASDAQ: ADBE shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779-1554.

In October 2023, an Adobe investor filed a lawsuit over alleged violations of securities laws by Adobe Inc. The plaintiff alleged that certain public statements made by Adobe between July 23, 2021, and September 15, 2022 related to competition from Figma and the adequacy of Adobe’s existing offerings to counter harms Adobe may have faced due to Figma’s growing market position were materially false and misleading.

On February 23, 2025, an amended complaint was filed and on March 29, 2024, the defendants filed their motion to dismiss the amended complaint.

On March 27, 2025, the court issued an order granting the defendants’ motion to dismiss. The plaintiff sought leave to amend the complaint in response to the court’s order, which the court denied on November 7, 2025 and the plaintiff is appealing the court’s orders in United States Court of Appeals for the Second Circuit in New York. (No. 25-3120).

Those who purchased shares of Adobe Inc. (NASDAQ: ADBE) long-term should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Contacts

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc.

NASDAQ:ADBE
Details

Release Versions

Contacts

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

More News From The Shareholders Foundation, Inc.

LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares in the U.S. District Court for the Northern District of California (No: 5:26-cv-07691). Investors, who purchased shares of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) have certain options. NASDAQ: PRCT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On...

LAWSUIT INVESTOR NOTICE: Investors who lost money with Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares should contact the Shareholders Foundation

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares in the U.S. District Court for Southern District of California (No: 3:26-cv-04385). Investors, who purchased a significant amount of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, in excess of $100,000 have certain options and there are short and strict deadlines running. Deadline: Sep...

Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares in the U.S. District Court for the Southern District of California (No: 3:26-cv-04643). Investors, who purchased a significant amount of Aardvark Therapeutics, Inc. (NASDAQ: AARD) between February 13, 2025 and May 14, 2026, in excess of $100,000 have certain options and there are short and strict deadlines running. Deadline:...
Back to Newsroom